We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Endoscopic Indicators for OACs After Lung Transplantation: Development of a Novel Mucosal Healing Score (OAC)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00940147
First Posted: July 15, 2009
Last Update Posted: June 6, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Thomas Fuehner, Hannover Medical School
  Purpose
Airway complications are a significant cause of morbidity after lung transplantation (LTx). Bronchoscopic evaluation may help to identify risk factors for requiring interventions later.

Condition
Airway Complication Which Require Any Intervention

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Early Indicators for Obstructive Airway Complications After Lung

Resource links provided by NLM:


Further study details as provided by Thomas Fuehner, Hannover Medical School:

Primary Outcome Measures:
  • Primary endpoint of this study was any obstructive airway complication (AC) which required desobliterative intervention. [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • secondary endpoint included anastomosis-related death. [ Time Frame: 1 year ]

Enrollment: 180
Study Start Date: January 2007
Study Completion Date: August 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
patients with OAC, Score finding
2
patients without OAC, Score finding

Detailed Description:
The investigators evaluated lung transplant recipients prospectively. Adult patients surviving 90 day after LTx will be included. The investigators propose a classification of airway healing based on the endoscopic bronchial appearances at days 7, 14, 21, 90, 180 and 365 after LTx. A score system including mucosal healing, full tissue necrosis (=dehiscence), lose sutures, fibrin plugs, polyps and malacia will be developed (max. score 8 points/date). Endoscopic findings will be correlated with the development of obstructive airway complications (OAC, requiring >1 intervention). Afterwards the new score system will be applied prospectively in the patients.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
LTx 01.2007-05.2009
Criteria

Inclusion Criteria:

  • 3 month survivor after LTx
  • no OAC

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00940147


Locations
Germany
Hannover Medical School
Hannover, Germany, 30625
Sponsors and Collaborators
Thomas Fuehner
  More Information

Additional Information:
Responsible Party: Thomas Fuehner, Principal Investigator, Hannover Medical School
ClinicalTrials.gov Identifier: NCT00940147     History of Changes
Other Study ID Numbers: 2008_01
OAC_1.0
First Submitted: July 14, 2009
First Posted: July 15, 2009
Last Update Posted: June 6, 2013
Last Verified: June 2013